Chen Yu-Pei, Wu Hong-Tan, Hwang Ing-Er, Chen Fang-Fang, Yao Jeng-Yuan, Yin Yiling, Chen Meng-Yun, Liaw Li-Ling, Kuo Yang-Cheng
Department of Public Health and Medical Technology, Xiamen Medical College, Xiamen, 361023, Fujian, China.
Engineering Research Center of Natural Cosmeceuticals College of Fujian Province, Xiamen Medical College, Xiamen, 361023, Fujian, China.
Bot Stud. 2022 Jul 2;63(1):20. doi: 10.1186/s40529-022-00351-y.
Medical plants confer various benefits to human health and their bioconversion through microbial fermentation can increase efficacy, reduce toxicity, conserve resources and produce new chemical components. In this study, the cholesterol-lowering monacolin K genes and content produced by Monascus species were identified. The high-yield monacolin K strain further fermented with various medicinal plants. The antioxidant and anti-inflammatory activities, red pigment and monacolin K content, total phenolic content, and metabolites in the fermented products were analyzed.
Monacolin K was detected in Monascus pilosus (BCRC 38072), and Monascus ruber (BCRC 31533, 31523, 31534, 31535, and 33323). It responded to the highly homologous mokA and mokE genes encoding polyketide synthase and dehydrogenase. The high-yield monacolin K strain, M. ruber BCRC 31535, was used for fermentation with various medicinal plants. A positive relationship between the antioxidant capacity and total phenol content of the fermented products was observed after 60 days of fermentation, and both declined after 120 days of fermentation. By contrast, red pigment and monacolin K accumulated over time during fermentation, and the highest monacolin K content was observed in the fermentation of Glycyrrhiza uralensis, as confirmed by RT-qPCR. Moreover, Monascus-fermented medicinal plants including Paeonia lactiflora, Alpinia oxyphylla, G. uralensis, and rice were not cytotoxic. Only the product of Monascus-fermented G. uralensis significantly exhibited the anti-inflammatory capacity in a dose-dependent manner in lipopolysaccharide-induced Raw264.7 cells. The metabolites of G. uralensis with and without fermentation (60 days) were compared by LC/MS. 2,3-Dihydroxybenzoic acid, 3,4-dihydroxyphenylglycol, and 3-amino-4-hydroxybenzoate were considered to enhance the antioxidant and anti-inflammatory ability.
Given that highly homologous monacolin K and citrinin genes can be observed in Monascus spp., monacolin K produced by Monascus species without citrinin genes can be detected through the complementary methods of PCR and HPLC. In addition, the optimal fermentation time was important to the acquisition of antioxidants, red pigment and monacolin K. These bioactive substances were significantly affected by medicinal plants over fermentation time. Consequently, Monascus-fermented G. uralensis had a broad spectrum of biological activities.
药用植物对人类健康有多种益处,通过微生物发酵进行生物转化可提高其功效、降低毒性、节约资源并产生新的化学成分。在本研究中,对红曲霉菌种产生的降胆固醇莫纳可林K基因及其含量进行了鉴定。用高产莫纳可林K菌株与多种药用植物进一步发酵。分析了发酵产物的抗氧化和抗炎活性、红色素和莫纳可林K含量、总酚含量及代谢产物。
在毛红曲霉菌(BCRC 38072)以及红曲霉菌(BCRC 31533、31523、31534、31535和33323)中检测到了莫纳可林K。它与编码聚酮合酶和脱氢酶的高度同源的mokA和mokE基因相关。高产莫纳可林K菌株红曲霉菌BCRC 31535用于与多种药用植物发酵。发酵60天后,观察到发酵产物的抗氧化能力与总酚含量呈正相关,而在发酵120天后两者均下降。相比之下,红色素和莫纳可林K在发酵过程中随时间积累,通过RT-qPCR证实,在甘草发酵中观察到最高的莫纳可林K含量。此外,包括白芍、益智、甘草和大米在内的红曲霉菌发酵药用植物无细胞毒性。只有红曲霉菌发酵甘草的产物在脂多糖诱导的Raw264.7细胞中以剂量依赖方式显著表现出抗炎能力。通过LC/MS比较了发酵(60天)和未发酵的甘草的代谢产物。2,3 - 二羟基苯甲酸、3,4 - 二羟基苯乙二醇和3 - 氨基 - 4 - 羟基苯甲酸被认为可增强抗氧化和抗炎能力。
鉴于在红曲霉菌种中可观察到高度同源的莫纳可林K和桔霉素基因,可通过PCR和HPLC的互补方法检测无桔霉素基因的红曲霉菌种产生的莫纳可林K。此外,最佳发酵时间对获取抗氧化剂、红色素和莫纳可林K很重要。这些生物活性物质在发酵过程中受药用植物的影响显著。因此,红曲霉菌发酵甘草具有广泛的生物活性。